CME Europe Cocoa Contract Reduces Potential Conflicts of Interest - Article 3

Queues for delivery at exchange-registered commodity warehouses, allegations of slow loading-out rates and high movement-out charges are symptoms of the existence of conflicts of interest between warehousekeepers, their customers, supervisors and the interests of futures exchanges offering deliverable futures contracts.  These conflicts pose a threat to the integrity of the relevant contracts.

CME Europe aims to address such issues in a market-led way to ensure the integrity of the contract by making the basis of its new deliverable cocoa futures contract:

  • ‘delivered out’;
  • introducing mandatory independent supervision of sampling and grading; and
  • defining the roles of parties involved.

Like the issues, the solution is three-fold.  The first involves the basis of the contract; CME Europe cocoa futures contract terms require the owner delivering the cocoa against an exchange position also pre-pays the delivery-out charge.  This is because the party storing the cocoa in the first place is able to choose the warehousekeeper – the party taking up the cocoa does not have that choice so it is equitable that the party storing the cocoa pays for the goods to be removed from the warehouse.  With this understanding, the ability of the warehousekeeper to charge the party taking up the cocoa to move the cocoa out is removed.  It is what occurs in the physical market when a potential buyer wishes to purchase goods stored with a warehousekeeper unknown to him, the seller will arrange to pay for those charges.  The CME Europe cocoa futures contract is reflecting common and natural practice in the underlying cash market.


This also has the benefit of market-control of warehouse rents as parties know that as the owner may remove his stock for no charge, the potential for the stock to be removed helps to keep the warehouse rents broadly in line and related to the costs of storage.  CME Europe does not intend to publish maximum warehouse rent rates and, as they are zero, has no need to publish the movement out charges. 

The second point is that since cocoa which passes grading is worth more to the owner and warehousekeeper, there is room for concern over the potential incentiveto draw  biased samples, one which is more likely to pass grading.  CME Europe, in its Procedures, stipulates ‘All sampling shall be supervised by a Licenced Supervisor or by the Registrar.  The Licenced Supervisor is responsible for the sampling being conducted in accordance with these Cocoa Procedures.’

The presence of an independent Licenced Supervisor appointed by the exchange minimises the scope  to draw an unrepresentative sample, the consequences of which  are not only may the warehousekeeper benefit from a potential increase in rental  and movement out charges, but also of  subsequent owners taking delivery of stock which is not correctly valued.

The third point is that there are three roles of activity in a warehoused deliverable futures contract which are best separated, namely:

  • Owner and Warehousekeeper;
  • Warehousekeeper and Supervisor & Grader; and
  • Supervisor and Grader.


The pressures of conflict of interest are increased when a warehousekeeper has a close relationship with the owner of the goods.  This may be divided into two:

a.     when there is a commercial contract between the warehousekeeper and owner; and

b.     when the warehousekeeper is owned by, or there is a formal corporate relationship with a company with a trading arm of the potential owner.

Under a. above, providing the terms of the relationship reflect commercial practice there is less concern, even if these relationships are deep and longstanding, as ensuring that the delivery out charge is pre-paid and that the sampling is conducted under independent supervision ensures objectivity in the storage and delivery process. 

The second b., poses an unfair situation as the warehousekeeping/trading entity may know the intentions of a competitor with stock stored with his subsidiary or corporate sister company.  At delivery, stock is distributed at random to buyers by the allocation algorithm of the Exchange delivery system, so a receiver may be allocated stock lying with any Registered Warehousekeeper.  Being allocated stock effectively stored with a warehousekeeping/trading competitor provides a source of potential private information to the competitor and needs to be addressed.  As these companies are not subject to regulated market conditions and pose an unfair advantage that cannot be resolved by commercial means it therefore means it should not be allowed.  The CME Procedures will not allow warehousekeepers  to become approved if they have a corporate relationship with a potential owner. 

As mention earlier, there is a potential conflict of interest between warehousing the goods and the assessment of their quality.  As sampling the goods is inextricably linked to the results from subsequent analysis of its quality, prudent independent assessment should ensure that no warehousekeeper may be allied or affiliated with the supervision of the drawing of the sample, nor to an entity analysing its quality. 

Under the CME Europe Cocoa futures contract Procedures, Registered Warehousekeepers cannot act as approved Supervisors, nor may they grade the cocoa samples.  All sampling in the Warehouse is supervised (the Supervisors appointed by the Exchange) and by the nature of the process for bulk cocoa, also includes the supervision of the weighing.  Once drawn, the Warehousekeeper will not have access to the grading sample as it remains in the hands of the Supervisor.  Again, contract integrity is the basis of this separation of roles.

In similar spirit, while the approved Supervisor may be involved in both the sampling and grading process, no individual as an employee of the approved Supervisor, i.e. Licensed Individual, may undertake both the sampling and grading of any individual sample.  An individual may do one but not the other.  In addition, note that any grading may only occur in the presence of a CME appointed representative.

By addressing directly the issues facing the delivery of cocoa, CME Europe consider that changing the basis of the contract to ‘delivered out’; mandatory supervision of sampling and the separation of the roles of those involved in the delivery process are essential in maintaining the integrity of the contract.

The next article will deal with the innovation of the CME Europe warrant handling and Depository.

Download PDF


“CME Group”, “CME Europe” and “CME Clearing Europe” are brands of CME Group Inc. and its subsidiaries, members of which include Chicago Mercantile Exchange Inc., CME Europe Limited, CME Clearing Europe Limited and CME Marketing Europe Limited.

Exchange traded and Over-The-Counter (OTC) derivatives are not suitable for all investors, and involve the risk of loss. Exchange traded and OTC derivatives are leveraged investments, and because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money initially deposited for an exchange traded or OTC derivative position. Therefore, traders should only use funds that they can afford to lose without affecting their lifestyles. And only a portion of those funds should be devoted to any one trade because they cannot expect to profit on every trade.

CME Group is the trademark of CME Group, Inc. The Globe logo, CME Globex® and CME® are trademarks of Chicago Mercantile Exchange, Inc. CBOT® is the trademark of the Board of Trade of the City of Chicago Inc. NYMEX, New York Mercantile Exchange, and CME Clearport are trademarks of New York Mercantile Exchange Inc. COMEX is a trademark of Commodity Exchange Inc. All other trademarks are the property of their respective owners.

The information within this presentation has been compiled by CME Group for general purposes only. Although every attempt has been made to ensure the accuracy of the information within this presentation, CME Group assumes no responsibility for any errors or omissions. Additionally, all examples in this presentation are hypothetical situations, used for explanation purposes only, and should not be considered investment advice or necessarily the results of actual market experience. All data is sourced by CME Group unless otherwise stated.

All matters pertaining to rules and specifications herein are made subject to and are superseded by official CME, CBOT, NYMEX, CME Europe, CME Clearing Europe and CME Group rules. Current rules should be consulted in all cases concerning contract specifications.

This communication does not constitute a Prospectus, nor is it a recommendation to buy, sell or retain any specific investment or to utilise or refrain from utilising any particular service. This communication is for the exclusive use of Eligible Counterparties and Professional Clients only and must not be relied upon by Private Clients who should take independent financial advice. Circulation should be restricted accordingly.

CME Europe Limited is a Recognised Investment Exchange (RIE) recognised and supervised by the Financial Conduct Authority in the United Kingdom. CME Clearing Europe Limited is a Recognised Clearing House (“RCH”) recognised and supervised by the Bank of England. CME European Trade Repository is a business name of CME Trade Repository Limited, a registered trade repository under EMIR supervised by the European Securities and Markets Authority. CME Globex Markets Limited is authorised and regulated by the Financial Conduct Authority.

Chicago Mercantile Exchange Inc. is a Recognised Overseas Clearing House (ROCH) recognised by the Bank of England. Chicago Mercantile Exchange Inc., Board of Trade of the City of Chicago and the New York Mercantile Exchange are Recognised Overseas Investment Exchanges (ROIE’s) recognised by the Financial Conduct Authority.

Issued by CME Marketing Europe Limited. CME Marketing Europe Limited (FRN: 220523) is authorised and regulated by the Financial Conduct Authority in the United Kingdom.

Copyright © 2015 CME Group. All rights reserved.